The Advantages of the Zero-COVID-19 Strategy
- PMID: 35886618
- PMCID: PMC9317662
- DOI: 10.3390/ijerph19148767
The Advantages of the Zero-COVID-19 Strategy
Abstract
Introduction: To curb the COVID-19 pandemic, countries across the globe have adopted either a mitigation or anelimination policy, such as the zero-COVID-19 strategy. However, further research is needed to systematically investigate the advantages of the zero-COVID-19 strategy in the literature. To bridge the research gap, this study examines the zero-COVID-19 strategy in terms of its advantages as a global anti-pandemic framework. Methods: A literature review was conducted in PubMed, PsycINFO, and Scopus to locate academic articles that discussed the advantages of the zero-COVID-19 strategy. Braun and Clarke's thematic analysis approach was adopted to guide the data analysis process. Results: The findings of our study show that the advantages of the zero-COVID-19 strategy range from short-term (e.g., limited virus infections, hospitalizations, and deaths), to medium-term (e.g., reduced presence of other infectious diseases), and long-term (e.g., low incidence of long COVID-19). While local residents mainly leverage these advantages, they also impact the global community (e.g., stable global supply of essentials, such as COVID-19 vaccines). Conclusions: COVID-19 is catastrophic, yet controllable. Our study examined the advantages of the zero-COVID-19 strategy from a nuanced perspective and discussed how these advantages benefit both the local and the global community in pandemic control and management. Future studies could investigate the shortcomings of the zero-COVID-19 strategy, especially its unintended consequences, such as adverse impacts on vulnerable populations' mental health, so that society could more efficiently, economically, and empathetically capitalize on the potential of the zero-COVID-19 strategy for the betterment of personal and public health.
Keywords: COVID-19; coronavirus; public health policies; virus elimination; zero-COVID-19 strategy.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- World Health Organization The True Death Toll of COVID-19: Estimating Global Excess Mortality. [(accessed on 30 April 2022)];2022 Available online: https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimat....
-
- Feng E. Can China’s Zero Tolerance Approach to Fighting the Delta Variant Work Forever? 2021. [(accessed on 4 October 2021)]. Available online: https://www.npr.org/2021/08/25/1031067091/china-delta-coronavirus-varian....
-
- Wong T. China: How Delta Threatens a Prized Zero COVID Strategy. 2021. [(accessed on 4 October 2021)]. Available online: https://www.bbc.com/news/world-asia-china-58095909.
-
- Global Times Virus Resurgence Raises Urgency of Improving Epidemic-Control Efficiency: Global Times Editorial. 2021. [(accessed on 4 October 2021)]. Available online: https://www.globaltimes.cn/page/202108/1230253.shtml.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous